IFNA1 and melanoma: Similarly, truncation in the β2-microglobulin gene resulting in defects in MHC-I-mediated antigen presentation and loss-of-function mutations to JAK1 or JAK2, implying defects to the transduction of antiviral IFN signals; mediate resistance to PD-1 blockade in melanoma [135].